vimarsana.com

Latest Breaking News On - Edwards lifesciences company profile - Page 2 : vimarsana.com

Intech Investment Management LLC Purchases 6,526 Shares of Edwards Lifesciences Co (NYSE:EW)

Intech Investment Management LLC boosted its position in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 65.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,450 shares of the medical research company’s stock after acquiring an additional 6,526 shares during the quarter. Intech […]

Edwards Lifesciences (NYSE:EW) Trading Down 1 4%

Edwards Lifesciences Co. (NYSE:EW – Get Free Report) fell 1.4% during mid-day trading on Tuesday . The company traded as low as $86.75 and last traded at $86.76. 316,813 shares changed hands during trading, a decline of 91% from the average session volume of 3,518,682 shares. The stock had previously closed at $87.98. Analyst Ratings […]

DSM Capital Partners LLC Takes Position in Edwards Lifesciences Co (NYSE:EW)

DSM Capital Partners LLC bought a new stake in Edwards Lifesciences Co. (NYSE:EW – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 371 shares of the medical research company’s stock, valued at approximately $28,000. Other institutional investors and hedge […]

Hoylecohen LLC Sells 542 Shares of Edwards Lifesciences Co (NYSE:EW)

Hoylecohen LLC trimmed its position in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 6.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,873 shares of the medical research company’s stock after selling 542 shares during […]

Skopos Labs Inc Takes Position in Edwards Lifesciences Co (NYSE:EW)

Skopos Labs Inc. acquired a new stake in Edwards Lifesciences Co. (NYSE:EW – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 4,094 shares of the medical research company’s stock, valued at approximately $312,000. Several other large investors have also made […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.